247 related articles for article (PubMed ID: 35117258)
1. Advances in the pathogenesis and treatment of nut carcinoma: a narrative review.
Wang S; Li J; Tong W; Li H; Feng Q; Teng B
Transl Cancer Res; 2020 Oct; 9(10):6505-6515. PubMed ID: 35117258
[No Abstract] [Full Text] [Related]
2. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment.
French CA
Pathol Int; 2018 Nov; 68(11):583-595. PubMed ID: 30362654
[TBL] [Abstract][Full Text] [Related]
3. BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
[TBL] [Abstract][Full Text] [Related]
4. NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V; Saluja K; Pina-Oviedo S
Front Oncol; 2022; 12():860830. PubMed ID: 35372003
[TBL] [Abstract][Full Text] [Related]
5. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract][Full Text] [Related]
6. NUT carcinoma, an under-recognized malignancy: a clinicopathologic and molecular series of 6 cases showing a subset of patients with better prognosis and a rare ZNF532::NUTM1 fusion.
Abreu RF; Oliveira TB; Hertzler H; Toledo RN; D'Almeida Costa F; Lopes Pinto CA; Nunes WA; Nascimento AF; French CA; Nascimento AG
Hum Pathol; 2022 Aug; 126():87-99. PubMed ID: 35623465
[TBL] [Abstract][Full Text] [Related]
7. NUT Carcinoma-An Underdiagnosed Malignancy.
Lauer UM; Hinterleitner M; Horger M; Ohnesorge PV; Zender L
Front Oncol; 2022; 12():914031. PubMed ID: 35957893
[TBL] [Abstract][Full Text] [Related]
8. Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.
Shiota H; Alekseyenko AA; Wang ZA; Filic I; Knox TM; Luong NM; Huang Y; Scott DA; Jones KL; Gokhale PC; Lemieux ME; Cole PA; Kuroda MI; French CA
Mol Cancer Res; 2021 Nov; 19(11):1818-1830. PubMed ID: 34285087
[TBL] [Abstract][Full Text] [Related]
9. NUT Is a Driver of p300-Mediated Histone Hyperacetylation: From Spermatogenesis to Cancer.
Rousseaux S; Reynoird N; Khochbin S
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565363
[TBL] [Abstract][Full Text] [Related]
10. An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients.
Chau NG; Ma C; Danga K; Al-Sayegh H; Nardi V; Barrette R; Lathan CS; DuBois SG; Haddad RI; Shapiro GI; Sallan SE; Dhar A; Nelson JJ; French CA
JNCI Cancer Spectr; 2020 Apr; 4(2):pkz094. PubMed ID: 32328562
[TBL] [Abstract][Full Text] [Related]
11. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.
Chau NG; Hurwitz S; Mitchell CM; Aserlind A; Grunfeld N; Kaplan L; Hsi P; Bauer DE; Lathan CS; Rodriguez-Galindo C; Tishler RB; Haddad RI; Sallan SE; Bradner JE; French CA
Cancer; 2016 Dec; 122(23):3632-3640. PubMed ID: 27509377
[TBL] [Abstract][Full Text] [Related]
12. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
[TBL] [Abstract][Full Text] [Related]
13. Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive
Zhou J; Duan M; Jiao Q; Chen C; Xing A; Su P; Tang J; Zhang H; Liu Z
Front Oncol; 2021; 11():778296. PubMed ID: 35127482
[TBL] [Abstract][Full Text] [Related]
14.
Zheng D; Elnegiry AA; Luo C; Bendahou MA; Xie L; Bell D; Takahashi Y; Hanna E; Mias GI; Tsoi MF; Gu B
Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38724194
[TBL] [Abstract][Full Text] [Related]
15. The BRD4-NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma.
Durall RT; Huang J; Wojenski L; Huang Y; Gokhale PC; Leeper BA; Nash JO; Ballester PL; Davidson S; Shlien A; Sotirakis E; Bertaux F; Dubus V; Luo J; Wu CJ; Keskin DB; Eagen KP; Shapiro GI; French CA
Cancer Res; 2023 Dec; 83(23):3846-3860. PubMed ID: 37819236
[TBL] [Abstract][Full Text] [Related]
16. Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.
Fekkar A; Emprou C; Lefebvre C; Ferretti G; Stephanov O; Pissaloux D; Mc Leer A; Toffart AC; Rousseaux S; Khochbin S; Lantuejoul S; Valmary-Degano S
Lung Cancer; 2021 Aug; 158():55-59. PubMed ID: 34119933
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological molecular characterizations of sinonasal NUT carcinoma: a report of two cases and a literature review.
Chen M; Li S; Jiang L
Front Oncol; 2023; 13():1296862. PubMed ID: 38239638
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study.
Jung M; Kim S; Lee JK; Yoon SO; Park HS; Hong SW; Park WS; Kim JE; Kim J; Keam B; Kim HJ; Kang HJ; Kim DW; Jung KC; Kim YT; Heo DS; Kim TM; Jeon YK
Oncologist; 2019 Aug; 24(8):e740-e748. PubMed ID: 30696721
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.
Wang R; You J
J Biol Chem; 2015 Jan; 290(5):2744-58. PubMed ID: 25512383
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
